Cognition Therapeutics (CGTX) Return on Assets (2021 - 2026)

Cognition Therapeutics (CGTX) has 6 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• Quarterly Return on Assets rose 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Assets improved to 0.01% in Q1 2026 per CGTX's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q1 2022 and bottomed at 0.02% in Q2 2025.
• The 5-year median for Return on Assets is 0.01% (2025), against an average of 0.01%.
• The widest annual swing landed in 2024, when Return on Assets fell 1 bps; it then grew 1 bps in 2025.
• Tracing CGTX's Return on Assets over 5 years: stood at 0.01% in 2022, then tumbled by 82 bps to 0.01% in 2023, then tumbled by 69 bps to 0.02% in 2024, then jumped by 44 bps to 0.01% in 2025, then grew by 3 bps to 0.01% in 2026.
• Per Business Quant, the three latest CGTX Return on Assets figures stand at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).

Peer Comparison